FDA Inspection 1004195 — Bayer AG
The FDA completed an inspection of Bayer AG on Jan 20, 2017 in Leverkusen. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jan 20, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Leverkusen (Germany)